Alterra, Wageningen UR, P.O. Box 47, 6700 AA Wageningen, The Netherlands.
J Hazard Mater. 2013 Oct 15;261:840-6. doi: 10.1016/j.jhazmat.2012.12.044. Epub 2013 Jan 3.
Bioavailability can form the basis for describing potential risks that contaminants pose to the environment and human health, and for determining remedial options to reduce risks of contaminant dispersal and toxicity. In assessments of polluted sites, methods to measure bioavailability can lead to a realistic appraisal of the potential risks from exposure to contaminants. For remediation purposes the application of the principles of bioavailability can result in practices that reduce bioavailability and consequently the risk of contaminants. Moreover the costs of remediation can be reduced. Examples from projects with organic contaminants (PAHs, pesticides and PFOS) and heavy metals in The Netherlands, Mali, Mauretania, Australia and Taiwan are presented. It is shown that using bioavailability principles in risk-based approaches is an attractive option in terms of both cost and in situ management of contaminated sites. Regulatory and public acceptance is, however, still the Achilles heel of these new remediation strategies.
生物可给性可作为描述污染物对环境和人体健康造成的潜在风险的基础,并确定减少污染物扩散和毒性风险的补救措施。在受污染场地的评估中,测量生物可给性的方法可以对接触污染物的潜在风险进行实际评估。出于修复的目的,生物可给性原则的应用可以导致减少生物可给性的实践,从而降低污染物的风险。此外,修复的成本也可以降低。本文介绍了来自荷兰、马里、毛里塔尼亚、澳大利亚和中国台湾的有机污染物(多环芳烃、农药和全氟辛烷磺酸)和重金属污染场地的项目实例。结果表明,在基于风险的方法中使用生物可给性原则在成本和受污染场地的原位管理方面都是一个有吸引力的选择。然而,监管和公众的接受仍然是这些新的修复策略的阿喀琉斯之踵。